215
Views
15
CrossRef citations to date
0
Altmetric
Review Article

Thromboprophylaxis in hip arthroplasty: New frontiers and future strategy

Pages 339-342 | Received 14 Feb 1998, Accepted 17 Apr 1998, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Randi M Hole, Anne Marie Fenstad, Jan-Erik Gjertsen, Stein A Lie & Ove Furnes. (2021) Thromboprophylaxis in primary shoulder arthroplasty does not seem to prevent death: a report from the Norwegian Arthroplasty Register 2005–2018. Acta Orthopaedica 92:4, pages 401-407.
Read now
Stein Atle Lie, Lars Birger Engesaeter, Leif Ivar Havelin, Ove Furnes & Stein Emil Vollset. (2002) Early postoperative mortality after 67,548 total hip replacements. Acta Orthopaedica Scandinavica 73:4, pages 392-399.
Read now
Elisabetta Cenni, Gabriela Ciapetti, Donatella Granchi, Susanna Stea, Lucia Savarino, Alessandra Corradini & Alessandro Di Leo. (2001) No effect of methacrylate-based bone cement CMW 1 on the plasmatic phase of coagulation, red blood cells and endothelial cells in vitro. Acta Orthopaedica Scandinavica 72:1, pages 86-93.
Read now
O E Dahl, D Bergqvist, A T Cohen, S P Frostick, R D Hull & B M Persson. (2001) Low-molecular-weight heparin as prophylaxis against thromboembolism after total hip replacement--The never-ending story?. Acta Orthopaedica Scandinavica 72:2, pages 199-204.
Read now

Articles from other publishers (9)

. (2022) Recommendations from the ICM-VTE: General. Journal of Bone and Joint Surgery 104:Suppl 1, pages 4-162.
Crossref
Daniel A. Hatef, Jeffrey M. Kenkel, Marilyn Q. Nguyen, Jordan P. Farkas, Fatemeh Abtahi, Rod J. Rohrich & Spencer A. Brown. (2008) Thromboembolic Risk Assessment and the Efficacy of Enoxaparin Prophylaxis in Excisional Body Contouring Surgery. Plastic and Reconstructive Surgery 122:1, pages 269-279.
Crossref
ZF Zairul-Nizam & YA Gul. (2016) Malaysian Orthopaedic Surgeons' Approach to Venous Thromboembolic Disease Prophylaxis: Attitudes and Practice. Journal of Orthopaedic Surgery 11:2, pages 178-183.
Crossref
Sean D Sullivan, Susan R Kahn, Bruce L Davidson, Lars Borris, Patrick Bossuyt & Gary Raskob. (2003) Measuring the Outcomes and Pharmacoeconomic Consequences of Venous Thromboembolism Prophylaxis in Major Orthopaedic Surgery. PharmacoEconomics 21:7, pages 477-496.
Crossref
E. Cenni, D. Granchi, M. Vancini & A. Pizzoferrato. (2002) Platelet release of transforming growth factor-β and β-thromboglobulin after in vitro contact with acrylic bone cements. Biomaterials 23:6, pages 1479-1484.
Crossref
Rocco Paolo Pitto, Hendrik Hamer, Renato Fabiani, Martin Radespiel-Troeger & Matthias Koessler. (2002) Prophylaxis Against Fat and Bone-Marrow Embolism During Total Hip Arthroplasty Reduces the Incidence of Postoperative Deep-Vein Thrombosis. The Journal of Bone and Joint Surgery-American Volume 84:1, pages 39-48.
Crossref
Robert Krotenberg, Uri Adler, Bruce Pomeranz, Jeffrey D. Miller & Mason W. Russell. (2001) Dalteparin vs. Enoxaparin as Prophylaxis for Deep-Vein Thrombosis After Total Hip or Knee Arthroplasty. American Journal of Physical Medicine & Rehabilitation 80:12, pages 889-895.
Crossref
P. Haentjens, P.H. Delincé, J. Boghemans, T. Borms, K. Brabants, J. Bremen, P. Cuyvers, G. de Brouckére, E De Groot, K. De Smet, I Debiére, Ph. DelincéD. Demedts, M. Dewijze, J. Dierckxsens, C. Dierickx, M. Eekhaut, A.-C. Gohimont, P. Haentjens, G. Hollaert, S. Meuris, M. Michaux, J. Peck, B. van Backlé, P. van Bouchaute, J. Van Gestel, M. van Hoye, J. van Overschelde, D. Vandevyver, D. Vanlommel & A. Velghe. (2018) Prevention of Venous Thromboembolism after Hospital Discharge Continued Pharmacological Prophylaxis versus No Prophylaxis in Patients Undergoing Total Hip Replacement. HIP International 11:1, pages 25-36.
Crossref
G. L. Plotkin, A. N. Petrov, I. P. Nikolayeva & A. A. Domashenko. (1999) Use of low-molecular heparine for the prevention of venous thromboses and embolisms in total hipreplacement. N.N. Priorov Journal of Traumatology and Orthopedics 6:4, pages 34-38.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.